The new ACC guideline provides information to clinicians on the management of atherosclerotic cardiovascular disease risk reduction in patients with persistent hypertriglyceridemia.
The association between high blood pressure and the prevalence of retinal atherosclerosis was examined.
The researchers addressed whether ziltivekimab safely and effectively reduced biomarkers of inflammation and thrombosis among patients with high cardiovascular risk and chronic kidney disease.
In a study presented at ACC 2021, the researchers assessed the cardioprotective effects of ezetimibe and statin combination therapy vs statin up-titration.
Researchers conducted a patient-level pooled analysis from phase 3 trials of inclisiran in patients with familial hypercholesterolemia or ASCVD.
The presence of cardiovascular risk factors and subclinical carotid atherosclerosis in midlife may be associated with brain hypometabolism.
Autopsy studies have shown that aortic and coronary artery atherosclerotic lesions are present in toddlers and progresses into adulthood. This study explores the development of coronary atherosclerosis due to non–HDL-C over three stages of life.
The risk for coronary artery calcification was found to be greater in women with a history of gestational diabetes despite attaining normoglycemia after pregnancy.
Rivaroxaban plus aspirin regimen for chronic atherosclerotic vascular disease may not require adjustment based on BMI or weight.
Recreational substance use is associated with an increased likelihood of premature and extremely premature atherosclerotic cardiovascular disease.
